Anti-LL-37 antibodies in synovial fluid reflect disease-specific immunopathogenic mechanisms in psoriatic arthritis
Open Access
- 5 September 2026
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Antimicrobial peptide cathelicidin LL-37 preserves intestinal barrier and organ function in rats with heat strokeBiomedicine & Pharmacotherapy, 2023
- Antibiofilm properties of cathelicidin LL-37: an in-depth reviewWorld Journal of Microbiology and Biotechnology, 2023
- The neutralising and stimulatory effects of antimicrobial peptide LL-37 in human gingival fibroblastsArchives of Oral Biology, 2023
- A stable cyclized antimicrobial peptide derived from LL-37 with host immunomodulatory effects and activity against uropathogensCellular and Molecular Life Sciences, 2022
- Rheumatologie im MedizinstudiumZeitschrift für Rheumatologie, 2020
- LL-37 restored glucocorticoid sensitivity impaired by virus dsRNA in lungInternational Immunopharmacology, 2020
- Effect of the Antimicrobial Peptide LL-37 on Gene Expression of Chemokines and 29 Toll-like Receptor-Associated Proteins in Human Gingival Fibroblasts Under Stimulation with Porphyromonas gingivalis LipopolysaccharideProbiotics and Antimicrobial Proteins, 2019
- Identification of Novel Autoantibodies Associated With Psoriatic ArthritisArthritis & Rheumatology, 2019
- Human keratinocyte cultures (HaCaT) can be infected by DENV, triggering innate immune responses that include IFNλ and LL37Immunobiology, 2018
- Classification criteria for psoriatic arthritis: Development of new criteria from a large international studyArthritis & Rheumatism, 2006